Inventor · disambiguated record
Ryo Mizojiri
Also filed as: MIZOJIRI RYO
9 granted patents·2 pending applications·40 citations·filing 2005–2022
81Inventor score
Files withTAKEDA PHARMACEUTICALS CO5JAPAN TOBACCO INC3MIZOJIRI RYO1TAKEDA PHARMACEUTICAL1YAMASHITA TOHRU1
Top patents by PatentIndex Score
11 records- 0187US7803801B2Aminopyridine compounds having Syk inhibitory activityJAPAN TOBACCO INC·Filed 2006·Granted Sep 28, 2010·25 cites·13 claims
- 0283US7659263B2Thienopyrrole compound and use thereof as HCV polymerase inhibitorJAPAN TOBACCO INC·Filed 2005·Granted Feb 9, 2010·11 cites·25 claims
- 0374US12435063B2Nitrogen containing heterocycles as CDK12 inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Oct 7, 2025·0 cites·15 claims
- 0473US9133129B2Bicyclic compoundTAKEDA PHARMACEUTICAL·Filed 2012·Granted Sep 15, 2015·3 cites·12 claims
- 0565US9605000B2Spiro azetidine isoxazole derivatives and their use as SSTR antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Mar 28, 2017·1 cites·12 claims
- 0663US11584737B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Feb 21, 2023·0 cites·15 claims
- 0748US2009036444A15-5-Membered fused heterocyclic compound and use thereof as HCV polymerase inhibitorJAPAN TOBACCO INC·Filed 2006·Application pending·0 cites
- 0840US2012020920A15-5-membered fused heterocyclic compound and use thereof as hcv polymerase inhibitorMIZOJIRI RYO·Filed 2011·Application pending·0 cites
- 0936US10301292B2Bicyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted May 28, 2019·0 cites·9 claims
- 1032US10252997B2Monocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Apr 9, 2019·0 cites·6 claims
- 1131US8703758B2Bicyclic compoundYAMASHITA TOHRU·Filed 2011·Granted Apr 22, 2014·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →